UA109243U - A SOLID MEDICINAL FORM CONTAINING PROTEASE INHIBITOR - Google Patents
A SOLID MEDICINAL FORM CONTAINING PROTEASE INHIBITORInfo
- Publication number
- UA109243U UA109243U UAU201510848U UAU201510848U UA109243U UA 109243 U UA109243 U UA 109243U UA U201510848 U UAU201510848 U UA U201510848U UA U201510848 U UAU201510848 U UA U201510848U UA 109243 U UA109243 U UA 109243U
- Authority
- UA
- Ukraine
- Prior art keywords
- protease inhibitor
- form containing
- containing protease
- solid medicinal
- medicinal form
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Тверда дозована форма, яка включає інгібітор ВІЛ протеази, як діючу речовину, причому інгібітором ВІЛ протеази є дарунавір або його фармацевтично прийнятні похідні, причому кількість дарунавіру (в перерахунку на безводну основу) становить від 200 мг до 1000 мг, а також щонайменше один або декілька фармацевтично прийнятних ексципієнтів, вибраних з групи, що включає: наповнювачі, дезінтегранти, лубриканти, ковзні речовини, плівкоутворювачі, пігменти, барвники, пластифікатори або їх комбінації.A solid dosage form comprising an HIV protease inhibitor as active substance, the HIV protease inhibitor being darunavir or its pharmaceutically acceptable derivatives, the amount of darunavir (in terms of anhydrous basis) being from 200 mg to 1000 mg, and at least one or more pharmaceutically acceptable excipients selected from the group comprising: fillers, disintegrants, lubricants, sliding substances, film-forming agents, pigments, dyes, plasticizers or combinations thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201510848U UA109243U (en) | 2015-11-06 | 2015-11-06 | A SOLID MEDICINAL FORM CONTAINING PROTEASE INHIBITOR |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201510848U UA109243U (en) | 2015-11-06 | 2015-11-06 | A SOLID MEDICINAL FORM CONTAINING PROTEASE INHIBITOR |
Publications (1)
Publication Number | Publication Date |
---|---|
UA109243U true UA109243U (en) | 2016-08-25 |
Family
ID=56707598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201510848U UA109243U (en) | 2015-11-06 | 2015-11-06 | A SOLID MEDICINAL FORM CONTAINING PROTEASE INHIBITOR |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA109243U (en) |
-
2015
- 2015-11-06 UA UAU201510848U patent/UA109243U/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
EA201792592A1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN | |
CL2018001199A1 (en) | Comprimido de tres capas que comprende un compuesto de formula i, tenofovir alafenamida y emtricitabina; su uso en el tratamiento de una infeccion por vih. | |
EA201691242A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AZD9291 | |
EA201792591A1 (en) | PHARMACEUTICAL PREPARATIONS | |
DOP2016000254A (en) | PHARMECEUTIC FORMULATIONS OF PAN-RAF QUINASE INHIBITOR, PROCEDURES FOR THEIR PREPARATION, AND METHODS OF USE. | |
EA201490222A1 (en) | COMBINED COMPOSITIONS BASED ON DARUNAVIR | |
EA201691490A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING BRINZOLAMIDE | |
CO2018001700A2 (en) | Derivatives of n- [1h-benzimidazol-2-yl] methyl-pyrazin-2-yl-carboxamide, compositions and methods of preparation thereof | |
CR20180091A (en) | 5- (N-BENCIL-TETRAHYDROISOQUINOLIN-6-IL) -PIRIDIN-3-IL ACETIC AS INHIBITORS OF HIV REPLICATION | |
ZA202006377B (en) | Boronic acid derivatives and therapeutic uses thereof | |
AR115913A1 (en) | BIO AVAILABLE ORAL DOSAGE FORMS, USE, METHODS | |
EA202090542A1 (en) | HIGHLY CONCENTRATED MEDICINAL FORMS OF Pridopidine | |
AR114418A1 (en) | CYCLIC COMPOUND OF METHYLACTAM AND ITS PHARMACEUTICAL USE | |
TR201721700A2 (en) | DISTRIBUTED FORMULATIONS OF SAXAGLIPT IN THE MOUTH | |
CL2018002848A1 (en) | Liquid phosphoplatin formulations | |
EA201890929A1 (en) | LOW DOSES OF DIPYRIDAMOL COMPOSITIONS FOR ORAL ADMINISTRATION AND THEIR USE | |
UA109243U (en) | A SOLID MEDICINAL FORM CONTAINING PROTEASE INHIBITOR | |
CO2021008962A2 (en) | Active Testosterone Ester Derivatives, Compositions and Uses Thereof | |
PE20171340A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL DISEASES | |
AR108792A1 (en) | COMPOSITIONS THAT INCLUDE TIMOLOL | |
AR099330A1 (en) | USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANEMIA | |
UA123399U (en) | PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE | |
EA201992296A1 (en) | Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors | |
AR106750A1 (en) | HIV MATURATION INHIBITOR FORMULATIONS |